Literature DB >> 509053

Is the investigation of patients with breast cancer for occult metastatic disease worth while?

A P Forrest, E L Cant, M M Roberts, H J Stewart, M D Sumerling, A A Donaldson, A F Smith, A A Shivas.   

Abstract

Entities:  

Mesh：

Year:  1979        PMID： 509053     DOI： 10.1002/bjs.1800661019

Source DB:  PubMed          Journal:  Br J Surg        ISSN： 0007-1323            Impact factor:   6.939


× No keyword cloud information.
  5 in total

1.  Value of bone scanning in the follow-up of breast cancer patients. A study of 1000 cases.

Authors:  H Schünemann; P J Langecker; W Ellgas; A Leonhardt; H Merkl
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

2.  Routine bone scanning in patients with T1 and T2 breast cancer: a waste of money.

Authors:  K A Yeh; L Fortunato; J A Ridge; J P Hoffman; B L Eisenberg; E R Sigurdson
Journal:  Ann Surg Oncol       Date:  1995-07       Impact factor: 5.344

3.  Tests for detecting recurrent disease in the follow-up of patients with breast cancer.

Authors:  J L Mansi; H M Earl; T J Powles; R C Coombes
Journal:  Breast Cancer Res Treat       Date:  1988-07       Impact factor: 4.872

4.  CA15-3: a reliable indicator of metastatic bone disease in breast cancer patients.

Authors:  D P O'Brien; P G Horgan; D B Gough; R Skehill; H Grimes; H F Given
Journal:  Ann R Coll Surg Engl       Date:  1992-01       Impact factor: 1.891

5.  Preoperative assessment and staging of breast cancer: preliminary communication.

Authors:  A P Forrest; R B Black; V Humeniuk; E L Cant; R A Hawkins; R J Prescott; M M Roberts; A A Shivas; H J Stewart; A F Smith; M Sumerling; M Sumerling
Journal:  J R Soc Med       Date:  1980-08       Impact factor: 18.000
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.